Tutorials
OSTO:KARO (Sweden)  
Karo Pharma AB logo

Karo Pharma AB

kr 50.60 (+1.2%) Aug 8
On watch
P/E:
At Loss
P/B:
1.67
Market Cap:
kr 13.83B ($ 1.36B)
Enterprise V:
kr 22.20B ($ 2.19B)
Volume:
37.81K
Avg Vol (2M):
40.74K
Also Trade In:
Volume:
37.81K
Market Cap kr:
13.83B
Market Cap $:
1.36B
PE Ratio:
At Loss
Avg Vol (2-Month):
40.74K
Enterprise Value kr:
22.20B
Enterprise Value $:
2.19B
PB Ratio:
1.67
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
Karo Pharma AB is a healthcare corporation. It is primarily engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector. The trademarks of the firm are Ibux, Paracet, Dosett, Allevo, and Swereco. It operates in the segment of research and development for drug discovery. The company carries its business operations in Sweden and internationally, of which the majority of the revenue is generated from Sweden and Norway.

Financials (Next Earnings Date:2022-10-28 Est.)

OSTO:KARO's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr) 2,961.453
EPS (TTM) (kr) -0.088
Beta 0.2
Volatility % 18.76
14-Day RSI 42.61
14-Day ATR (kr) 1.105759
20-Day SMA (kr) 51.155
12-1 Month Momentum % -3.33
52-Week Range (kr) 49.25 - 64.63687
Shares Outstanding (Mil) 273.25

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Karo Pharma AB Filings

Document Form Filing Date
No Filing Data